# US 2023/0322807 A1 · Process for the Steroselective Preparation of Chiral 2-[(Hetero)Arylalkylsulfanyl]Pyrimidines and Products Obtainable Therefrom

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0322807 A1
- Document ID: US20230322807A1
- Status: Published application
- Kind: A1
- Application number: 18/199,899
- Filed: 2023-05-19
- Published: 2023-10-12
- Earliest claimed: 2018-05-15
- Assignees: Kancera AB
- Applicants: Kancera AB
- Inventors: Jan Vågberg; Styrbjörn Byström
- Web page: https://patentgrep.com/patent/US20230322807A1

## CPC

- C07D 513/04: Ortho-condensed systems
- C07D 239/56: One oxygen atom and one sulfur atom
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

Described herein is a process for the preparation of a compound of Formula I, wherein R1 and R2 each have the meanings provided in the description. Also described is a process for the preparation of pharmaceutically-active compounds including the process for the preparation of compounds of Formula I.

## Claims

### Claim at position 1

1-32. (canceled)

### Claim 33

A compound having a structure:
or a salt thereof, with a chiral purity of greater than 99.7%.

### Claim 34 (depends on 1)

The compound as claimed in claim 1, with a chiral purity of at least 99.8%.

### Claim 35

A pharmaceutical composition comprising a compound having a structure:
or a salt thereof, with a chiral purity of greater than 99.7%.

### Claim 36 (depends on 3)

The pharmaceutical composition of claim 3, wherein the compound has a chiral purity at least 99.8%.
